Sheena Aurora, MD, medical fellow and global launch leader, Eli Lilly and Company, Indianapolis.
Migraine relief may soon include lasmiditan, the first in a new class of migraine drug in 20 years—rapid relief without heart and blood pressure risks.
Copyright © 2019 Bottom Line Inc. 3 Landmark Square Suite 201 Stamford, CT 06901
Bottom Line, Inc. publishes the opinions of expert authorities in many fields These opinions are for educational and illustrative purposes only and should not be considered as either individual advice or as a substitute for legal, accounting, investment, medical and other professional services intended to suit your specific personal needs. Always consult a competent professional for answers specific to your questions and circumstances. Our content is further subject to our Terms and Conditions